Beneficiaries must be enrolled in a Part D plan Medicare Part D beneficiaries must be enrolled in a Part D PDP or MA-PD plan for calendar year 2026 to qualify to receive GLP-1s under the Bridge Program
Mapping potential trade-offs would clarify where present approaches leave residual risk or unmet need, and provides the appropriate rationale for evaluating additive surface strategies that aim to improve peri-implant health without sacrificing established benefits
That environment can create a false sense of confidence
PlexusDx's pricing modelat $289/mo month-to-month, or from $249/mo on the 6-month plan flatmeans your cost remains the same whether you're at a lower or higher dose, removing financial barriers to safe dose adjustment
Novo Nordisk holds South African patents for Ozempic and Wegovy, both of which use semaglutide as their active ingredient
Following a confirmed episode of pancreatitis, Ozempic should not be restarted , as stated in the SmPC